Answer
Yes, severe liver injury has been reported with vemurafenib; liver enzymes and bilirubin should be measured before treatment and monitored monthly during treatment, or as clinically indicated.
Sources for this answer
- Zelboraf 240 mg Film-coated TabletsRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 30Document updated
Sources checked